Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 116 (1) , 232-242
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- Oregon National Primate Research Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Clinical and Translational Science Institute, University of California, Los Angeles (UL1TR001881)
- National Institutes of Health (P50HD071836, P51 ODO11092)
This publication has 44 references indexed in Scilit:
- Adipogenesis: From Stem Cell to AdipocyteAnnual Review of Biochemistry, 2012
- Cross‐Talk between PPARγand Insulin Signaling and Modulation of Insulin SensitivityPPAR Research, 2009
- Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3Fertility and Sterility, 2008
- Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of womenJournal of Endocrinology, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Screening Women With Polycystic Ovary Syndrome for Metabolic SyndromeObstetrics & Gynecology, 2005
- Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndromeJournal of Internal Medicine, 2005
- Plasma Adiponectin and Endogenous Glucose Production in HumansDiabetes Care, 2003
- C/EBPα induces adipogenesis through PPARγ: a unified pathwayGenes & Development, 2002
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999